PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Vikas Mohan Sharma

Neuraxpharm (Spain)

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines1

Latest

Everything in the corpus, newest first.

JUL 6, 2026 · JOURNAL ARTICLE

Desvenlafaxine as a Potential First-Line Treatment for Major Depressive Disorder: A Comprehensive Review and Consensus-Based Clinical Perspective on Efficacy, Safety and Patient Selection Profiles

Clinical Drug Investigation

A narrative review and expert consensus statement synthesizing published evidence on desvenlafaxine for MDD, without new primary data or meta-analysis, to inform clinical selection and first-line positioning.

Expert GuidanceCancer Research and Treatment Claudia Carmassi António Vian-Lains

Study details

DesignNarrative review with expert consensus

InterventionDesvenlafaxine (serotonin-noradrenaline reu…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support